Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-05-27

FDA Approved: ATOVAQUONE AND PROGUANIL HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a generic version of atovaquone and proguanil hydrochloride for the treatment and prevention of malaria (ANDA 202362, Mylan).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (atovaquone and proguanil hydrochloride)

Snippet

ORIG AP for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)